CIK 0001427570 · <br>Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-25 | VandenBerg Amy Chief Clinical & Reg Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-10-25 | MacDonald Robert J Chief Retail Officer | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2019-10-25 | Hussainy Nooshin Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +11,682 | 11,682 | ||
| 2019-10-25 | Hussainy Nooshin Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +9,000 | 9,000 | ||
| 2019-10-25 | Plovanic William J. President & CEO | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-08-06 | Brister Mark Chief Technology Officer | Purchase | +5,000 | $4.00 | $20K | 38,865 |
| 2019-08-06 | Brister Mark Chief Technology Officer | Purchase · Warrants (Right to Buy) | +3,750 | 3,750 | ||
| 2019-08-06 | MacDonald Robert J Chief Retail Officer | Purchase | +5,000 | $4.00 | $20K | 5,245 |
| 2019-08-06 | MacDonald Robert J Chief Retail Officer | Purchase · Warrants (Right to Buy) | +3,750 | 3,750 | ||
| 2019-08-06 | Hussainy Nooshin VP of Finance | Purchase | +5,000 | $4.00 | $20K | 16,340 |
| 2019-08-06 | Hussainy Nooshin VP of Finance | Purchase · Warrants (Right to Buy) | +3,750 | 3,750 | ||
| 2019-08-06 | Rasdal Andrew P Exec Chairman of the Board | Purchase | +12,500 | $4.00 | $50K | 77,892 |
| 2019-08-06 | Rasdal Andrew P Exec Chairman of the Board | Purchase · Warrants (Right to Buy) | +9,375 | 9,375 | ||
| 2019-08-06 | Plovanic William J. President & CFO | Purchase | +12,500 | $4.00 | $50K | 41,806 |
| 2019-08-06 | Plovanic William J. President & CFO | Purchase · Warrants (Right to Buy) | +9,375 | 9,375 | ||
| 2019-08-06 | VandenBerg Amy Chief Clinical & Reg Officer | Purchase | +2,500 | $4.00 | $10K | 11,764 |
| 2019-08-06 | VandenBerg Amy Chief Clinical & Reg Officer | Purchase · Warrants (Right to Buy) | +1,875 | 1,875 | ||
| 2019-08-06 | HOWE LESLEY H Director | Purchase | +6,250 | $4.00 | $25K | 19,397 |
| 2019-08-06 | HOWE LESLEY H Director | Purchase · Warrants (Right to Buy) | +4,687 | 4,687 | ||
| 2019-08-06 | Stevenson Sharon Director | Purchase | +7,500 | $4.00 | $30K | 18,061 |
Page 8 of 10 · 185 trades